Azathioprine Completed Phase 4 Trials for Immune Thrombocytopenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03229746Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia